In order to obtain recognition, by at least one other Member State of the European Community or party to the Agreement on the European Economic Area, of a marketing authorisation granted by the Director General of the Agence nationale de sécurité du médicament et des produits de santé, with France acting as the reference State, the holder of this authorisation asks the latter to update or prepare the assessment report for the medicinal product; he/she sends the Agency any additions to the dossier available to the Agency.
The Director General of the Agency will send this assessment report, together with the summary of product characteristics, labelling and package leaflet, to the States concerned and to the marketing authorisation holder within ninety days of receipt of the complete dossier:
1° If these documents are approved by each of the States concerned within ninety days, the Director General of the Agency will notify these States and the marketing authorisation holder of the agreement.
2° If no agreement is reached within the period mentioned in 1°, the Director General of the Agency refers the matter to the coordination group mentioned in Article 27 of Directive 2001/83/EC of the European Parliament and of the Council.